- Investor's Business Daily•22 hours ago
Sanofi makes sense as an acquirer for Flexion Therapeutics, an analyst said Friday, but Flexion investors were dubious.
This week's highlights include rumors regarding Sanofi (SNY) acquiring Flexion, accelerated FDA approval for a Pfizer/Merck KGaA drug and drug pricing.
- Investor's Business Daily•2 days ago
Flexion Therapeutics stock rocketed to an 18-month high Thursday on rumors that it accepted a $1 billion offer from French drugmaker Sanofi put in a $1 billion bid to acquire it.
SAN.PA : Summary for SANOFI - Yahoo Finance
Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
|Bid||71.12 x 1000|
|Ask||71.74 x 44000|
|Day's Range||82.42 - 83.11|
|52 Week Range||62.50 - 83.86|
|PE Ratio (TTM)||22.82|
|Dividend & Yield||3.35 (3.75%)|
|1y Target Est||N/A|